View Older Stories View More Recent Stories

Dec 12, 2025 08:43AM Cytokinetics receives positive CHMP opinion for heart drug MYQORZO
Dec 8, 2025 07:32AM Piper Sandler on Biotechnology: 'What Commercial Names to Own in 2026?'
Dec 1, 2025 09:24AM Cytokinetics (CYTK) PT Raised to $61 at UBS
Nov 11, 2025 08:38AM Cytokinetics (CYTK) PT Raised at RBC Capital into Aficamten 2026 Launch
Nov 10, 2025 07:31AM Cytokinetics presents additional MAPLE-HCM trial data at medical conferences
Nov 5, 2025 04:04PM Cytokinetics (CYTK) Misses Q3 EPS by 98c
Oct 21, 2025 08:47AM Cantor Fitzgerald Reiterates Cytokinetics (CYTK) at Overweight Post Model Update
Oct 6, 2025 02:25AM Cytokinetics (CYTK) PT Raised to $82 at Barclays
Oct 1, 2025 07:14AM Cytokinetics (CYTK) PT Lowered to $95 at Stifel
Sep 30, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
Sep 29, 2025 02:58PM Cytokinetics (CYTK) October 40 calls and January 55 calls active
Sep 29, 2025 07:07AM Stifel Reiterates Buy Rating on Cytokinetics (CYTK)
Sep 23, 2025 04:19AM Citizens JMP Reiterates Market Outperform Rating on Rapport Therapeutics (RAPP)
Sep 23, 2025 04:18AM Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)
Sep 22, 2025 06:06AM H.C. Wainwright Reiterates $120 PT Cytokinetics (CYTK), Top Pick
Sep 16, 2025 04:12PM Cytokinetics meets with FDA on aficamten drug application
Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
Sep 3, 2025 10:39AM Jefferies on Cytokinetics (CYTK): 'we await some indication that these initiatives will deliver the intended results'
Sep 3, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
Sep 2, 2025 10:25AM Cytokinetics (CYTK) PT Raised to $96 at Stifel
Sep 2, 2025 09:35AM Truist: 'We Remain Buyers of Cytokinetics (CYTK)'
Sep 2, 2025 07:20AM Cytokinetics presents aficamten data at cardiology congress
Aug 7, 2025 04:04PM Cytokinetics (CYTK) Tops Q2 EPS by 30c, provides guidance
Jul 29, 2025 04:26PM Raymond James Assumes, Downgrades Cytokinetics (CYTK) to Market Perform
Jul 22, 2025 05:00AM Citi Adjusts North American Focus List
Jun 9, 2025 05:09AM Cytokinetics (CYTK) PT Lowered to $53 at JPMorgan
May 29, 2025 06:36AM Cytokinetics (CYTK) PT Lowered to $84 at Mizuho
May 27, 2025 09:51AM Stifel Reiterates Buy Rating on Cytokinetics (CYTK)
May 13, 2025 08:26AM Stifel on Cytokinetics (CYTK): 'we remain confident in a best-in-class opportunity for aficamten'
May 13, 2025 07:30AM Cytokinetics (CYTK) Announces Positive Topline Results From MAPLE-HCM
May 7, 2025 05:28AM Cytokinetics (CYTK) PT Lowered to $60 at Evercore ISI
May 7, 2025 05:05AM Cytokinetics (CYTK) PT Lowered to $80 at Citi
May 7, 2025 04:13AM Citizens JMP Reiterates Market Outperform Rating on Cytokinetics (CYTK)
May 6, 2025 04:04PM Cytokinetics (CYTK) Tops Q1 EPS by 1c
May 2, 2025 05:52AM Citizens JMP Reiterates Market Outperform Rating on Cytokinetics (CYTK)
May 1, 2025 04:17PM Cytokinetics (CYTK) Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy
Apr 24, 2025 04:17AM Barclays Starts Cytokinetics (CYTK) at Overweight
Apr 22, 2025 07:04AM H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
Apr 21, 2025 09:53AM H.C. Wainwright on Cytokinetics (CYTK): 'Less Restrictive Label for Camzyos in oHCM; We Still Project Cleaner Label for Aficamten; Reiterate Top Pick'
Apr 21, 2025 08:01AM Stifel Reiterates Buy Rating on Cytokinetics (CYTK)
Apr 15, 2025 05:23AM Cytokinetics (CYTK) PT Lowered to $54 at BofA Securities
Apr 15, 2025 04:10AM Citizens JMP Reiterates Market Outperform Rating on Cytokinetics (CYTK)
Apr 11, 2025 09:44AM Piper Sandler: 'What Biotech Names to Own in Market Volatility'
Apr 10, 2025 04:06AM Citizens JMP Reiterates Market Outperform Rating on Cytokinetics (CYTK)
Apr 4, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
Apr 3, 2025 07:33AM Cantor Fitzgerald Reiterates Overweight Rating on Cytokinetics (CYTK)
Apr 3, 2025 04:07AM Citizens JMP Reiterates Market Outperform Rating on Cytokinetics (CYTK)
Apr 2, 2025 01:46PM Raymond James Reiterates Outperform Rating on Cytokinetics (CYTK), PT $81
Apr 2, 2025 09:22AM Morgan Stanley Reiterates Overweight Rating on Cytokinetics (CYTK)
Mar 20, 2025 07:31AM Cytokinetics (CYTK) Announces Launch of EARTH-HCM
View More Recent Stories View Older Stories